Agreed Joint-efforts to Build Up the New Era of MEBO in South Korea Achieved by High-level Talk of Three Parties

2011年-12月-02日来源：MEBO

Invited by the President of MEBO International Marketing Group and after well-preparation and considerate arrangement, Ch. Y. Tao, the Managing Director of Hando Corporation of South Korea, accompanied with Yong Ki Lee, the Sales Headquarter Director of Dongwha Pharm., Jae Whan Kim, the Department Manager of the General Hospital Business Division of Dongwha Pharm., Kyoung Soo Ko, the Team Manager of Dongwha Pharm. and others, a team of ten people, visited MEBO International Group Beijing Headquarters officially during the Nov.. Dongwha Pharm, established in 1897, has enjoyed a long history of more than 110 years, and it is one of top 10 famous medical Groups in South Korea, with the staff number reaching more than 5000. Besides, the trademark “Paper Fan” is well-known in South Korea. Though having cooperated with MEBO Group for 16years, this was the first time that South Korean dealers organized this high-level visit to MEBO. During the visit, the host and her guests firstly reviewed the cooperation history in the past 16 years, and besides, they made a deep talk on the series of business topics including the current market situation and the future market development direction, etc.. The details as follows:

At 15:00 on November 3, the South Korean team led by Director Tao, Manager Lee and Team Manager Ko, accompanied by SUN Yuan, the Regional Manager of MEBO South Korea, attended the designed high-level business talk held in MEBO Beijing Headquarters. SUN Xia, the President of MEBO International Marketing Group, and LIU Gang, the Marketing Manager welcomed them warmly in the VIP Room Group. During the talks, Manager SUN gave a detailed introduction to the rapid development achieved by MEBO International Group in recent years and also the series products of MEBO, by which Manager Lee of Dongwha Pharm. was shocked. And he expressed his intense interest on MEBO career and asked some questions about the current development of MEBO in Russia and India. Moreover, President SUN introduced the overall strategy and plans of international Market development at present, and stressed that since South Korea is one of the earliest international market of MEBO and has always being the most important and promising market of MEBO, but presently it is a little lag behind, and so much effort and work need to be devoted to expand its development, and she hoped that through the concerted efforts of the three parties, MEBO market in South Korea can be carried forward to achieve the grand aim of popularizing and expand MEBO products and technology to a brand new level.

In order to further strengthen the knowledge of the visiting team towards MEBO technology and products, a vivid Regenerative Medicine Therapy training lecture was carefully arranged for them. SHU Ye, the head of General Technology Dept., introduced the application specifications of MEBO Ointment in detail to the visiting team and showed them a lot of the actual cases of amjor intensive burns to verify the unparalleled t reatment efficacy of MEBO. The Team Manager Gao of Dongwha Pharm. proposed many questions on MEBO how to deal with super-virus such as VRE, MRSA and etc, to help patients prevent infections; XU Yuan-Hao, the agent, learned from technical staff the treatment efficacy of MEBO in treating bedsores and others. After the training lecture, the General Technical Support Director, WAng Yi-fei gave a detailed introduction to the Life300Y Club and menwhile, showed the miracle regenerative effects of regenerative restoration technology by drawing on the live example of the club members, by which the visiting team was shocked.

In 2011, the event “Bribery Investigation in Medical Field” in South Korea badly hit the development of the pharmaceutical industry and caused an unprecedented impact to it, which led to major pharmaceutical companies burdening tens of millions of dollars losing, many small and medium sized pharmaceutical companies coming to bankruptcy or reorganization. A “big shuffle” in medical and pharmaceutical industry was the direct consequence of this event. However, opportunities and risks often walk hand in hand, because every "shuffle" will eliminate a number of products and companies that can not stand the market storms, while a group of mature, promising products and companies will adjust its strategy to go through the wind and waves, and finally grow up. The high-level meeting among MEBO, Hando Corporation and Dongwha Pharm. at this key time means a lot. MEBO products has entered Korean market for 16 years, the visit of South Korean side, with such a large-scale high-profile, fully reflected their faithful cooperation desire and firm confidence in MEBO technology and products. Under the brand new market development situation, let us believe that through the concerted efforts of the three parties, MEBO technologies and products in the Korean market will usher in a new tomorrow!

MEBO International Marketing Group

28 Nov. 2011